Survival In Advanced Diffuse Large B-Cell Lymphoma In Pre- and Post-Rituximab Eras In The United States: A Population Based Study

被引：0
|
作者：
Bista, Amir
Shafii, Bahman
Shah, Binay K.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1747.1747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1747
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era
    Yang, Deok-Hwan
    Ahn, Jae-Sook
    Byun, Byung Hyun
    Min, Jung Joon
    Kweon, Sun-Seog
    Chae, Yee Soo
    Sohn, Sang Kyun
    Lee, Sang Woo
    Kim, Hae Won
    Jung, Sung-Hoon
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Bom, Hee-Seung
    Lee, Je-Jung
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 471 - 479
  • [32] Survival trends of primary testicular diffuse large B-cell lymphoma: A population-based study
    Mousa, M.
    Meshref, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era
    Deok-Hwan Yang
    Jae-Sook Ahn
    Byung Hyun Byun
    Jung Joon Min
    Sun-Seog Kweon
    Yee Soo Chae
    Sang Kyun Sohn
    Sang Woo Lee
    Hae Won Kim
    Sung-Hoon Jung
    Yeo-Kyeoung Kim
    Hyeoung-Joon Kim
    Hee-Seung Bom
    Je-Jung Lee
    Annals of Hematology, 2013, 92 : 471 - 479
  • [34] Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era
    Morton, Lindsay M.
    Cerhan, James R.
    Hartge, Patricia
    Vasef, Mohammad A.
    Neppalli, Vishala T.
    Natkunam, Yasodha
    Dogan, Ahmet
    Dave, Bhavana J.
    Jain, Smrati
    Levy, Ronald
    Lossos, Izidore S.
    Cozen, Wendy
    Davis, Scott
    Schenk, Mary Jean
    Maurer, Matthew J.
    Lynch, Charles F.
    Rothman, Nathaniel
    Chatterjee, Nilanjan
    Yu, Kai
    Staudt, Louis M.
    Weisenburger, Dennis D.
    Wang, Sophia S.
    INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS, 2011, 2 (03): : 245 - 252
  • [35] The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B-cell lymphoma
    Habbous, Steven
    Guo, Helen
    Beca, Jaclyn
    Dai, Wei Fang
    Isaranuwatchai, Wanrudee
    Cheung, Matthew
    Chan, Kelvin K. W.
    CANCER MEDICINE, 2020, 9 (19): : 7072 - 7082
  • [36] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [37] PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Rozman, S.
    Grabnar, I.
    Novakovic, S.
    Mrhar, A.
    Novakovic, B. Jezersek
    HAEMATOLOGICA, 2017, 102 : 688 - 688
  • [38] Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era
    Dinnessen, Manette A. W.
    Maas, Carolien C. H. M.
    Tonino, Sanne H.
    Visser, Otto
    Posthuma, Eduardus F. M.
    Blijlevens, Nicole M. A.
    Kersten, Marie Jose
    Lugtenburg, Pieternella J.
    Dinmohamed, Avinash G.
    LEUKEMIA, 2022, 36 (05) : 1416 - 1420
  • [39] Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era
    Manette A. W. Dinnessen
    Carolien C. H. M. Maas
    Sanne H. Tonino
    Otto Visser
    Eduardus F. M. Posthuma
    Nicole M. A. Blijlevens
    Marie José Kersten
    Pieternella J. Lugtenburg
    Avinash G. Dinmohamed
    Leukemia, 2022, 36 : 1416 - 1420
  • [40] Rituximab maintenance therapy in diffuse large B-cell lymphoma
    Trajkova, S.
    Panovska-Stavridis, I.
    Stojanovik, A.
    Dukovski, D.
    Cevreska, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S22 - S23
12345